cordant for the presence of CHDs, is required to improve our knowledge on how postzygotic genetic, environmental and stochastic factors can affect human heart development. Copyright © 2012 S. Karger AG, Basel Somatic mosaicism is defined by the presence of genetically distinct populations of somatic cells in a single organism. Somatic mutations are implicated in an increasing variety of genetic disorders, and may induce a milder phenotype, hereby complicating diagnosis and genetic counseling. The mutation size ranges from base pair level to megabase-sized chromosomal segments [Erickson, 2010] . Studies investigating the role of mosaicism in the genesis of congenital heart defects (CHDs) have evoked conflicting results. CHDs arise from an abnormal heart development, induced either by environmental influences [Jenkins et al., 2007] , by an altered gene dosage or function [Bruneau, 2008] , by stochastic factors [Kurnit et al., 1987] or by combinations thereof. Human genetic studies have implicated mutations of numerous genes and chromosomal regions in CHD. A high prevalence of somatic point mutations in specific cardiac genes have been reported by
a single research group in DNA extracted from formalinfixed affected cardiovascular tissue of patients with nonsyndromic septal defects [Reamon-Buettner and Borlak 2004a , b, 2005 Reamon-Buettner et al., 2007 , 2008 . These mutations were not present in unaffected tissue of the same patients, suggesting a role of somatic mutations in the pathogenesis of CHD. However, these findings could not be replicated by other research groups using fresh-frozen cardiac tissues rather than formalin-fixed tissues [Majumdar et al., 2006; Draus et al., 2009; Salazar et al., 2011] . Poor DNA quality from formalin-fixed tissue presumably resulted in artifacts [Draus et al., 2009] .
Studies addressing the role of somatic copy number variation (CNV) in the genesis of CHDs are scarce [Notini et al., 2008; Erickson, 2010] . Recently, using array comparative genomic hybridization (aCGH) experiments on DNA derived from fully differentiated tissues, the presence of CNV differences between unaffected cardiac tissue and the cerebellar cortex of a single individual was evidenced by Piotrowski et al. [2008] . However, to date, no causal somatic CNVs in CHD were detected. Since germline deletions on 22q11.2 are a common chromosomal cause of syndromic conotruncal heart defects, Rauch et al. [2004] searched for somatic 22q11.2 copy number changes in fresh-frozen cardiac tissues from 14 patients with conotruncal heart defects without a germline deletion on this locus. However, no somatic 22q11.2 deletions were found.
We investigated whether CNV differences in monozygotic (MZ) twins discordant for CHDs may improve our insight into chromosomal mosaicism in CHDs. Discordant MZ twins represent an intriguing observation, as they are derived from a single fertilization event, and are considered to be genetically identical. Any CNV identified in 1 twin but not in the other would have a somatic origin, and would be an example of mosaicism . In this study, we aimed to investigate the role of somatic CNV events in 6 MZ twin pairs discordant for the presence of CHDs.
Patients and Methods

Patients
Six MZ twin pairs were recruited from the pediatric cardiology unit and Center for Human Genetics of the University Hospitals Leuven. The twins were discordant for a CHD. The cardiac phenotype and extracardiac anomalies of the affected twins are depicted in table 1 . CHDs were excluded in all non-affected twin members by means of echocardiography. Medical history of the non-affected twin members was unremarkable with respect to congenital defects, dysmorphism and developmental delay, with the exception of the 'non-affected' member of twin pair 6, who died neonatally due to severe multicystic renal disease and aplasia of the bladder, which resulted in oligohydramnion and a Potter sequence. Prenatal ultrasound was not suggestive of twin-to-twin transfusion syndrome (TTTS), except for twin pair 1, undergoing laser ablation at 24 weeks of gestation. Twin pair 3 was of Asian origin, twin pair 1 of African origin. All other twin pairs originated from 2 Caucasian parents. Familial history was negative with respect to congenital anomalies and developmental delay. Peripheral blood for DNA extraction was taken within the first week of life, except for twin pair 4, from whom DNA samples were taken at 4 years of age. Conventional karyotyping (G-banding analysis at least at ISCN +550 bands) was normal in all patients.
The study was approved by the Ethics Committee at the University Hospitals Leuven. Appropriate informed consent was obtained from all participating patients or their legal representatives.
Methods
Array Comparative Genomic Hybridization
Peripheral blood-derived DNA from both twins and sexmatched reference samples was hybridized to a 180-k oligo array platform (OGT CytoSure Syndrome Plus array, OGT Oxford, UK) according to the manufacturer's instructions with minor modifications as described in Srisupundit et al. [2010] . To identify inter-twin CNV differences as well as potential intra-twin CNVs contributing to the phenotype, DNA from each twin was hybridized against its co-twin, and against a genetically wellcharacterized normal control. All hybridizations were done in duplicate, with the Cy3 and Cy5 dyes being swapped between the twin members of each pair in the second hybridization to eliminate a possible dye-specific bias.
Data Analysis
The CytoSure Interpret software (OGT) was used to visualize the data and perform the analysis. Thresholds for CNV calling were set at 8 0.36 from a log2 ratio of 0, and at least 5 consecutive probes within a segment, achieving a theoretical resolution of 80 kb for targeted regions and of 16 kb for targeted genes [Srisupundit et al., 2010] . For a region to be called as discrepant between both twin members, it had to be present in both datasets within the dye-swap experiment.
An internal database of 'benign' CNVs at ϳ 200 kb resolution could be constructed by applying array experiments in healthy control individuals by means of the CytoSure Syndrome Plus V2 105K array (OGT). CNVs were also considered phenotypically indifferent when within regions reported in 1 1% of healthy controls by at least 2 independent research groups in the Database of Genomic Variants (http://projects.tcag.ca/variation/).
Confirmatory Tests
To confirm the presence of CNV differences, quantitative polymerase chain reaction (qPCR) was performed on DNA from both twin members and 3 unrelated controls (2 males and 1 female) using the LightCycler 480 Real-Time PCR system (Roche Applied Science, Belgium, https://www.roche-applied-science. com/lightcycler-online/), following the manufacturer's instructions. Quantitative PCR was performed as described by Menten et al. [2006] . Reference primers were selected within the TP53 gene, whereas reference primers within the MID1 gene were selected for CNVs on the X chromosome. For every potential intertwin CNV difference 2 PCR fragments were analyzed. Every qPCR experiment was performed in duplicate. The average of both analyses per PCR fragment was calculated. Oligonucleotide primer sequences are available upon request. All genome coordinates were determined according to NCBI human genome build 36 (hg18, March 2006).
Results
Array comparative genomic hybridization was performed on peripheral blood-derived DNA from 6 MZ twin pairs. Nine potential inter-twin CNVs were detected, representing 7 gains and 2 losses in 3 twin pairs (no. 1, 3 and 6) (online suppl. table 1, for all online suppl. material see www.karger.com/doi/10.1159/000335284). The average size was 36 kb (median 6 kb), and average probe count was 22 (median 9 probes). Six of these copy number differences were excluded by means of qPCR: 4 CNVs were not confirmed (false-positive), and 2 CNVs were present in both twin members (false-negative in 1 twin member). The 3 remaining CNV differences involved copy number gains in the affected member of twin pair 6, and were confirmed independently by qPCR. The average values for 1 PCR fragment of the confirmed intertwin differences were depicted in figure 1 . The average log2 ratio of one of these duplications was 1.25, whereas a ratio of 1.50 should be expected ( fig. 1 , table 2 ) . Copy number variants can cause CHDs with a reduced penetrance (e.g. 22q11 duplication). As a consequence, CNVs present in both twins, might affect heart development of only 1 member. Therefore, CNVs present in both twins were evaluated using an algorithm for CNV interpretation in patients with CHD, which was reported recently by our group [Breckpot et al., 2011] . In summary, copy number variants which are not recurrently found in 1 1% of normal individuals can be considered causal when they comprise known dosage-sensitive heart genes or known chromosomal syndromes. Rare CNVs not affecting genes or regions known to be involved in CHDs should be regarded as unclassified. Following this algorithm, none of the CNVs present in both members of a twin pair were considered to be causal for CHD.
Discussion
Monochorionic twins are at increased risk for CHDs, occurring in 5-7% of monochorionic diamniotic twins [Manning and Archer, 2006; Bahtiyar et al., 2007] . A proportion of these may result from altered hemodynamics during development due to placental vascular anastomoses [Manning and Archer, 2006; Bahtiyar et al., 2007] .
Virtually all monochorionic twin placentae have vascular anastomoses, which can be located superficially on the placenta (i.e. arterioarterial and venovenous), or form capillary connections in the placental parenchyma (i.e. arteriovenous or oppositely directed arteriovenous connections). Depending on the size, type and direction, these anastomoses may provoke large uncompensated fetofetal transfusions, which results in a discordant hemoglobin concentration between the twins or TTTS [Manning and Archer, 2006; Bahtiyar et al., 2007] . Recently, hemodynamic analyses unveiled the presence of additional 'deep-hidden' anastomoses, which cannot be coagulated by laser therapy as done for TTTS. Although the incidence of deep-hidden anastomoses is significant (in 50-70% of monochorionic twin placentae), the hematological (hemoglobin differences) and clinical consequences are considered to be limited [Wee et al., 2005; Lewi et al., 2006; van den Wijngaard et al., 2007] .
Approximately 15-35% of monochorionic diamniotic twin pregnancies are complicated by TTTS, 6.9% of which are associated with CHD. Cardiovascular changes, such as ventricular hypertrophy and right ventricle outflow tract obstruction, occur predominantly in recipient twins of TTTS pregnancies [Karatza et al., 2002; Bahtiyar et al., 2007; Divanovic et al., 2011] . In our study, prenatal ultrasound was not suggestive of TTTS, except for twin 1, of which the donor was diagnosed with a ventricular septal defect.
TTTS is typically diagnosed between 15 and 26 weeks of gestation, based on inter-twin differences in amniotic volume on prenatal ultrasound and flow abnormalities on Doppler evaluation. First-trimester diagnosis of TTTS is challenging, as no reproducible correlations between first-trimester measurements (e.g. inter-twin differences in crown-rump length or in nuchal translucency thickness) and the presence of TTTS could be established [El Kateb et al., 2007] . Studies addressing the role of altered hemodynamics during early heart development, before human embryonic day 32, are scarce. Four-dimensional Doppler optical coherence tomography, recently introduced for hemodynamic measurements during avian heart tube development [Jenkins et al., 2010] , might enable the study of hemodynamic changes at early stages of heart development in MZ twin models.
The challenge remains how to explain the discordance in cardiac development observed in monochorionic twins without obvious fetofetal transfusions and in dichorionic MZ twins where altered hemodynamics does not play a role. One possibility is that the MZ twinning process in itself increases the incidence of CHD, with postzygotic Quantitative PCR results of the 3 confirmed CNV differences between the members of twin pair 6. Quantitative PCR results are shown for the affected and unaffected (UA) member of twin pair 6, as well as for 3 unrelated normal controls (2 males (M), 1 female (F)). The boxes represent the average log2 ratios for 1 PCR fragment within the corresponding region (indicated as a red box in online suppl. fig. 1 ). The affected twin member harbors a discordant duplication on 12p13.31, Xp11.23 and Xq28. The log2 ratio was at 1.25 for the region on 12p13.31, which may indicate mosaicism of this CNV in the blood of the CHD-positive twin.
unequal division of the inner cell mass or disturbance of laterality being responsible for discordant cardiovascular anatomy. Other possible explanations are postzygotic genetic, epigenetic mutations and stochastic factors [Gringras and Chen, 2001; Singh and O'Reilly, 2009] . Previously, multiple CNV differences were detected by means of a 32-k BAC array on peripheral blood-derived DNA from 9 MZ twin pairs discordant for Parkinson's disease . There were 31 loci that deviated in 3 discordant MZ pairs and 4 loci that deviated in 4 such pairs. Similarly, Sasaki et al. [2011] identified a discordant loss of the SHC2 gene in the affected member of 1 MZ twin, discordant for multiple system atrophy. Subsequently, this SHC2 deletion was found in 10 out of 31 unrelated patients with multiple system atrophy, but not in normal controls, and, therefore, was deemed causal for the multiple system atrophy phenotype in the affected twin member. Conversely, 2 recent aCGH studies on peripheral blood-derived DNA from 1 MZ twin pair discordant for breast cancer and from 3 MZ twin pairs discordant for schizophrenia failed to reproduce the presence of intertwin CNV differences [Lasa et al., 2010; Ono et al., 2010] .
We aimed to investigate the role of postzygotic CNV events in MZ twin pairs discordant for CHDs. One twin pair was found to carry 3 copy number differences, involving 3 duplications in the CHD-positive member. The copy number gain on chromosome 12 reached a log2 ratio of about 1.25 by qPCR, whereas an expected ratio of 1.50 was obtained for a positive (female) control and for other duplications occurring in both members of twin pair 6, suggesting that this duplication was present as a mosaic in the blood of the CHD-positive twin, compatible with the hypothesis of a postzygotic somatic event. Unfortunately, no other tissue of this twin was available to reproduce the results.
The Xq28 duplication partially affects the FLNA gene. Loss-of-function mutations in FLNA have been described in families with X-linked cardiac valvular dysplasia [Kyndt et al., 2007] and in boys with CHDs associated with nodular periventricular heterotopias [Jefferies et al., 2010] or otopalatodigital syndrome [Kondoh et al., 2007] . A similar duplication partially comprising FLNA and EMD was detected once, in a normal control from the HAPMAP population [Perry et al., 2008] . The ELK1 gene on Xp11.23 encodes a ternary complex factor that acts as a repressor of smooth muscle proliferation [Wang et al., 2004] , but its potential role in heart development remains unexplored. The other genes within the duplicated segments are not known to be involved in the genesis of CHDs either. Further studies are required to determine whether the detected CNV differences are contributive to the patient's cardiac phenotype.
Tissue sampling is an important element when studying somatic events in twins, as the genotype of 1 tissue analyzed (usually blood) might not always be relevant to the genotype of the tissue responsible for the disease . Moreover, in many cases, the hematopoietic lineages of MZ twins are chimeric due to twin-to-twin exchange of hematopoietic stem cells during embryogenesis [Erlich, 2011] . Therefore, CNV profiles on DNA derived from a buccal smear, fibroblasts or cardiac tissue may differ from those obtained on peripheral blood-derived DNA, as was shown by Rohrer et al. in MZ twins discordant for Turner syndrome [Rohrer et al., 2004] . Cardiac tissue is however difficult to obtain, especially in non-affected individuals, and saliva samples were not available. Furthermore, the age at which (blood) samples are taken might theoretically influence somatic CNV profiles as well, since cellular subpopulations carrying a low-grade mosaic CNV can show impaired cell growth, and therefore gradually disappear in blood over time. Conversely, at an older age, inter-twin CNV differences could be induced by chromosomal rearrangements in hematologic malignancies, as shown by Bruder et al. [2008] . A longitudinal study in larger cohorts of MZ twins of different age is required to assess the impact of age on somatic CNV profiles. In our study, DNA samples were taken within the first week of life in 5 out of 6 MZ twin pairs.
In the absence of causal CNV differences, the question remains whether other genetic or epigenetic factors underlie the discordance of CHD in MZ twins. With the advent of (epi)genome-wide sequencing technologies, the answer to this is within our reach. Although exome sequencing data on MZ twins are still scarce, epigenetic differences in MZ twins have been identified in various diseases and tissues, either at selected genes [Petronis et al., 2003; Oates et al., 2006] or epigenome-wide [Fraga et al., 2005; Kaminsky et al., 2009 ]. In a cross-sectional study, Fraga et al. [2005] showed that MZ twins were epigenomically similar during their early years of life, indicative of high epigenetic heritability. However, epigenomes significantly diverged with age. The role of the environment was indicated by the fact that higher epigenetic variability was found in twins who differed more in lifestyle [Fraga et al., 2005; Wong et al., 2010] . Age-related epigenomic changes will definitely improve our understanding of complex traits, such as autoimmune disorders [Baranzini et al., 2010] or arterial hypertension, rather than that of inborn disorders, such as CHDs. Nev-ertheless, the broad application of genome and epigenome sequencing on MZ twins discordant for the presence of CHD will improve our knowledge on how genetic, environmental and stochastic factors can affect heart development.
In conclusion, we detected 3 CNV differences in 1 out of 6 MZ twin pairs discordant for the presence of CHD, confirming the occurrence of somatic CNV events in MZ twins. However, further studies are required to causally relate these CNVs to the cardiac phenotype. Copy number, genome and epigenome analyses in a larger MZ twin cohort are required to explore the role of somatic CNVs and mutations in the genesis of CHD.
